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Who Should Manage Periprosthetic Joint Infection?  
The Case for a Multidisciplinary Approach
S. yacovelli, J. Parvizi
Rothman Orthopedic Institute, Thomas Jefferson University Hospital,  
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abstract
Periprosthetic joint infection (PJI) following total joint arthroplasty (TJA) is a complex disease state that is quite 
devastating to those affected. Improvement in diagnostic testing modalities and therapeutic techniques have led 
to significant advances in treatment for patients, but there is still a considerable gap in treatment success across 
providers and institutions. Where and who should be treating cases of PJI remains a debated topic. Many experts have 
proposed a new treatment model not dissimilar to that with which has been used to treat other complex disease states 
such as cancer for decades, and there is now a growing body of evidence to support such a strategy is superior. In this 
article, we evaluate the current body of literature on the topic and offer recommendations for the ideal treatment 
model for PJI: the multidisciplinary approach. 
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Кто должен лечить перипротезную инфекцию: 
необходимость мультидисциплинарного подхода
С. Яковелли, Д. Парвизи
Ортопедический институт Ротмана, Университетский госпиталь Томаса Джефферсона, 
Филадельфия, США
реферат
Перипротезная инфекция (ППИ) после тотального эндопротезирования является сложным заболеванием, 
разрушительным для организма пациентов. улучшение методов диагностики и лечения привело к значи-
тельному прогрессу в лечении этой патологии, но все еще существует значительный разрыв в успехе лече-
ния среди поставщиков и учреждений. где и кто должен лечить пациентов с ППИ остается темой дискуссии.  
Многие эксперты предлагают новую модель лечения, не отличающуюся от той, которая использовалась в те-
чение десятилетий для лечения других сложных заболеваний, таких как рак, и в настоящее время появляется 
все больше доказательств того, что такая стратегия является лучшей. В этой статье авторы приводят ана-
лиз современной литературы по этой теме и предлагают междисциплинарный подход в качестве идеальной  
модели лечения ППИ.
Ключевые слова: перипротезная инфекция, тотальное эндопротезирование, междисциплинарный поход 
к лечению. 
Background
Periprosthetic joint infection (PJI) is a devastat-
ing complication of total joint arthroplasty (TJA) that 
leads to significant patient morbidity and mortality. 
Rates of infected knees following total knee arthro-
plasty (TKA) have been reported at 0.92% and rates 
of infected hips following total hip arthroplasty (THA) 
have been reported at a slightly lower rate of 0.88% 
[1]. The number of TJA cases overall have steadily 
increased in the united States over the past decade, 
likely due in part to an aging population and the obe-
sity epidemic. The increasing incidence of PJI, coupled 
with improvements in understanding and diagnostic 
testing, means there will be further demand on the 
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health care system to adequately treat this complex 
complication of TJA in an appropriate and cost-effec-
tive manner. 
Diagnostic testing has also greatly expanded our 
understanding of PJI, resulting in a need for a new 
definition to meet the needs of clinicians handling 
these cases. The Musculoskeletal Infection Society 
(MSIS) attempted to address these concerns and pro-
vide a uniform definition and diagnostic algorithm 
for PJI in 2011. The advent and widespread avail-
ability of empirically validated serum and synovial 
markers for PJI led to a further refined diagnostic cri-
teria recommended by the International Consensus 
Meeting (ICM) by 2018 [2]. While beyond the scope of 
this chapter, the definition includes a number of ma-
jor and minor criteria, consisting of culture growth, 
serum CRP, ESR, and D-Dimer, synovial fluid WBC, 
Leukocyte Esterase, PMN%, histological changes, 
and physical examination findings. This definition, 
while admittedly complex, allows clinicians to iden-
tify PJI despite its heterogeneous presentation and 
even categorize it as acute or chronic. Such nuanc-
es of the definition itself need to be recognized as 
they can have a profound impact on clinical decision 
making and patient outcomes, and as such, are best 
made by orthopedic specialists with experience in 
treating PJI. unfortunately, change and complexity 
require time and experience to adjust to. Tetreault 
et al. evaluated the consistency of current methods 
for evaluating PJI according to American Academy of 
Orthopaedic Surgeons (AAOS) guidelines and not-
ed an alarming gap between expectation and real-
ity, even amongst orthopedic-trained surgeons. The 
study concluded that there is still significant under-
diagnosis of PJI, leading to unnecessary order of ad-
vanced diagnostic imaging, adding to medical costs 
and a delay in treatment [3, 4].
The complexity of PJI doesn’t stop at its diagnosis 
either. Various treatment strategies must be personal-
ized on an individualized basis, and adjusted through-
out the period of care in order to offer the best out-
come possible. The decision to perform a single stage 
vs two stage revision, which antibiotic should be used 
and for how long it should be used for, how to medi-
cally optimize patients preoperatively, and whether 
or not to progress to a salvage procedure such as ar-
throdesis or amputation are just a few of the clinical 
decisions that need to be made on a multi-disciplinary 
level, led by an orthopedic surgeon with experience in 
treating PJI [5, 6]. 
For these reasons many experts have likened the 
ideal model with which we should treat PJI to that 
of the cancer care model: The multidisciplinary ap-
proach [7, 8]. In fact, the management of both disease 
states is exceedingly complex, and patient outcomes 
are arguably comparable between the two. PJI can 
be devastating, with patient mortality higher than 
many common forms of cancer, at 5-year rates of 25-
33% following two-stage exchange procedures [7, 9]. 
While the intricacy of cancer cases has been recog-
nized for a long time, it was not until recently that 
PJI was recognized as an entity that requires a co-
ordinated and collaborative effort amongst a variety 
of medical professionals in order to deliver the best 
care possible [10].
multidisciplinary approach
The days of surgeon-centered practice are long 
gone. Care for patients in nearly all fields has to, 
and needs to continue to, involve a multidisciplinary 
team of medical professionals [5, 7, 11]. This involves 
communication throughout patient care, from diag-
nosis to follow-up, with contributions from numer-
ous specialists. This is best done with establishment 
of hospital protocol based on guidelines specific for 
the treatment of PJI, under the lead of a subspecial-
ized orthopedic surgeon with experience in treating 
PJI [10].
As stated previously, this begins as early as the 
diagnostic workup. Contributions from infectious 
disease (ID) specialists, microbiologists, and radi-
ologists are necessary right from the start [9, 11]. for 
example, radiologists aid in recommendation of the 
most appropriate imaging modality and advise which 
areas to biopsy based on a case by case basis. In ad-
dition, ID specialists can offer information on how 
long antibiotics should be stopped prior to aspira-
tion, among other contributions. Once diagnosed, 
patients need to be preoperatively optimized prior to 
surgery if possible [9, 12, 13]. Endocrinology, hema-
tology, and nephrology are just a few of the medicine 
specialists that can help to minimize surgical risk, 
focusing on premorbid conditions such as diabetes, 
preoperative anemia, and chronic kidney disease, 
respectively, all of which are known risk factors for 
reinfection. Perioperatively, collaboration between 
surgeons and the anesthesia team is crucial as well. 
Hypotensive neuraxial anesthesia, use of tranexam-
ic acid, and antibiotic administration are a few well 
known considerations that should be discussed be-
fore cases. Patients should be followed closely by 
a multidisciplinary team following surgery as well 
[9]. Nurse navigators, home health care providers, 
and nursing home staff can communicate patient 
progress and monitor for complications. The list of 
providers and their roles goes on and on and var-
ies depending on the patient and care environment. 
Surgeons should be aware of the team members at 
their disposal and efforts should be made to establish 
a protocol to facilitate this process [5].
The superiority of multidisciplinary care for pa-
tients with osteoarthritis undergoing primary joint 
replacement has been well documented and routine-
ly practiced for years [7, 14]. Surgeons, anesthesiolo-
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gists, social workers, and physical therapists all play 
a role in the care of patients before and after surgery. 
Establishing an interdisciplinary care team to man-
age a patient together at the same facility has been 
shown to decrease length of stay and improve func-
tional outcomes [14]. This is likely due to the imple-
mentation of customized treatment plans and great-
er comorbidity management.7 Knowing this, it can be 
deduced that a similar model may prove to be even 
more effective for the treatment of the most difficult 
complication of total joint arthroplasty; PJI. There 
is evidence in the literature to support this claim as 
well [11, 15]. Ntalos et al. studied the effect of estab-
lishing a weekly multidisciplinary infection confer-
ence consisting of orthopedic surgeon, pathologists, 
microbiologists, and radiologists and found that 
it led to significant differences in treatment plans. 
Prior to this the hospital was using a single-disci-
pline approach with trauma surgeons managing care 
and antibiotic choice. Furthermore, this study also 
found that by implementing multidisciplinary con-
ferences for PJI cases, length of stay was decreased, 
particularly in those diagnosed with chronic PJI. This 
may lead to improved quality of life and lower hospi-
tal costs as well [8].
Specialized Centers and Case Volume
Access to a multidisciplinary group of healthcare 
providers is often difficult, and high-volume, spe-
cialized treatment centers are often best equipped 
to provide such care [6, 16, 17]. For this reason, 
treatment with a multidisciplinary approach and 
treatment at a high-volume tertiary care center are 
closely intertwined [5]. Specialized treatment cent-
ers have long reported better outcomes after prima-
ry TJA. (Bannister) In addition, fellowship-trained 
orthopedic surgeons who treat a high-volume of pa-
tients are better equipped to handle complex cases, 
and have likely developed a more refined surgical 
technique, established muscle memory, high atten-
tion, and faster recall [17]. Both hospital volume 
and surgeon volume are associated with improved 
clinical outcomes including decreased morbidity, 
mortality, and length of stay [16]. Complication 
rates after primary TJA were found to drop off sig-
nificantly after a surgeon reaches a case volume of 
35 per year [18]. It can be reasonably extrapolated 
that a similar association would be found between 
PJI case volume and outcome measurements. While 
the number of required revisions to define “high-
volume” is currently unknown, ICM has set the rec-
ommendation for case volume to be a minimum 
of 25 based off this knowledge [17]. In addition to 
surgical technique, surgeons must be familiar with 
diagnostic and treatment algorithms that have been 
empirically proven on an international level to im-
prove outcomes after PJI [3, 4]. 
Given the rarity of PJI cases, meeting the volume 
needed to gain expertise is difficult even at tertiary re-
ferral centers, let alone general hospitals. One strategy 
to address this and increase case volume for surgeons 
practicing in less densely populated settings may be 
to assign one or two surgeons with subspecialty inter-
est and experience to handle PJI. While the literature 
on this strategy is fairly scarce, a study done by Matar 
et al. found that such specialists at a general hospital 
were able to produce comparable results when com-
pared to a high-volume tertiary center if given an ad-
equate caseload [16]. If this is not possible, PJI cases 
that present to general hospitals should strongly be 
considered for referral [12].
Who Should Be Treated at a General 
Hospital? Who Should Be Referred?
In an ideal world, there is only one circumstance 
in which patients should be treated at a community 
hospital by an unexperienced surgeon. The unstable 
patient, presenting with acute sepsis as a result of a 
PJI should be treated promptly prior to referral [12]. 
In this circumstance, catastrophe is imminent, and 
it is common sense that they cannot be transferred. 
However, it is recommended that all other cases be 
transferred prior to surgical management [11, 19]. 
This includes patients who present in stable condi-
tion with acute post-operative, acute hematogenous, 
or chronic infection [12]. This recommendation was 
previously based on clinical judgment. However, it is 
now supported by the literature as well. Prior surgi-
cal intervention has been found to increase the risk 
of failure of subsequent surgical management of PJI 
[12, 19]. The prevalence of culture-negative PJI was 
also found to be much higher when surgical interven-
tion is attempted prior to referral to a tertiary care 
center, making management much more difficult [19]. 
Furthermore, patients with a history of prior treat-
ment failure for PJI have been found to undergo less 
salvage procedures when treated at a high volume 
center as well, offering a possible prevention strategy 
for this circumstance [5, 6, 11]. 
unfortunately, medicine can only be practiced 
within the constraints already set in place and while 
the evidence supports the creation of specialized 
tertiary centers and the use of a multidisciplinary 
approach as a long term solution, this may not be 
feasible under the current infrastructure [7]. In the 
meantime, patients should be risk-stratified in order 
to ensure that difficult cases are treated appropriately 
by orthopedic surgeons with the most experience in 
PJI. Patients at risk for infection after primary TJA are 
the same patients at high risk of recurrent infection 
and can be identified and referred even before in-
fection takes place. Factors such as body mass index 
(BMI), malnutrition, Diabetes Mellitus (DM), Chronic 
Kidney Disease (CKD), smoking, and cardiovascular 
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disease, among others, should all be taken into ac-
count.20 Continuity of care can be maintained if these 
patients are treated at specialized centers as well, 
which could help decrease the burden put on patients 
and their families. 
If PJI has already been diagnosed, identifying 
which patients are at risk for failure of treatment 
and require referral also is clearer than ever. Kheir 
et al. developed a risk calculator for failure of treat-
ment of PJI that may help in identifying such cases 
and found that, in descending order of importance; 
the need for irrigation and debridement, history of 
MI, revision surgery, presence of a sinus tract, cul-
ture of a resistant organism, smoking, history of 
prior surgery, synovial white blood cell count, body 
mass index, and erythrocyte sedimentation rate 
were all associated with an increased risk of treat-
ment failure of PJI [13].
The superiority of treatment of complex cases by 
specialized centers is becoming evident as well. A 
study recently published by Ibrahim et al focused on 
the treatment of such cases, including patients with 
immunocompromise, systemic disease, concurrent 
sepsis, reinfection, and complex anatomy such as 
bone loss, significant soft-tissue compromise, and 
unidentified organisms, treated at a tertiary center 
with a high volume of PJI cases by multidisciplinary 
approach. The results of the study were that only 
3 of 81 cases were reinfected. They reported a 90% 
eradication of MRSA infection with only 2 of 20 
patients becoming reinfected, which is staggering 
compared to previous failure rates reported in the 
literature [11].
conclusion
Periprosthetic Joint Infection is a complex disease 
state that requires constant communication and col-
laboration between a multidisciplinary team in order 
to provide the best treatment possible. Ideally, PJI 
cases should be treated by subspecialized surgeons 
who have experience treating a high volume of cas-
es. Hospitals that aren’t able to accommodate such 
patients should refer to centers that can, except in 
the unstable patient [3, 12, 19]. If this is not feasi-
ble, patients should be risk stratified, and transfer of 
the most complex cases to centers with experience in 
treating such cases is recommended. Standard pro-
tocols consistent with published guidelines to treat 
PJI should be established and adhered to at hospitals 
and, if possible, networks between general and ter-
tiary centers should be established to provide sup-
port [5, 10, 16]. 
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